Amarnath Singh
Instructor
Also affiliated: Babu Banarasi Das University (2015–2021); The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (2022–2025); The Ohio State University (2022–2026); Council of Scientific and Industrial Research (2006–2017); Indian Institute of Toxicology Research (2006–2021); Academy of Scientific and Innovative Research (2019)
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Amarnath Singh studies the health impacts of environmental exposures, particularly polycyclic aromatic hydrocarbons (PAHs) and indoor air pollution. His research has investigated the association between occupational exposure to airborne PAHs in kitchens and adverse lung functions, as well as kidney dysfunction among kitchen workers in India. Singh has also examined the link between PAH exposure and lung cancer through meta-analysis. His work also includes developing methods for extracting and analyzing PAH metabolites in biological samples. Beyond environmental health, Singh has contributed to research on soil pollution remediation using artificial intelligence and the production of biopolymers from food waste. His scholarship metrics include an h-index of 13, 29 total publications, and 805 total citations.
Metrics
- h-index: 14
- Publications: 29
- Citations: 811
Positions
-
Instructor 2026–presentUniversity of Arkansas for Medical Sciences Department of Environmental Health Sciences ORCID
-
Postdoctoral Research Fellow 2024–2026University of Arkansas for Medical Sciences Department of Environmental Health Sciences ORCID
-
Postdoctoral Research Fellow 2019–2024The Ohio State University Wexner Medical Center Comprehensive Cancer Center ORCID
Selected Publications
-
Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer (2026)
-
DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy (2025)
-
A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity (2025)
Collaboration Network
Top Collaborators
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy
- Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- A narrative review of metabolomics approaches in identifying biomarkers of doxorubicin-induced cardiotoxicity
- DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy
- DNA Methylation in Lung Cancer: Predictive Biomarkers for Effective Immunotherapy
- Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
- Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
- Metabolic phenotypes of doxorubicin-induced cardiotoxicity among patients with breast cancer
Similar Researchers
Based on overlapping research topics